News
Patient dosing underway in CALiPSO-1 trial in the U.S.: In March 2025, the first patient was dosed in the Phase 1 CALiPSO-1 trial which is currently evaluating CNTY-101 as a potential treatment for ...
First successful allogeneic stem cell transplant using deceased donor in blood cancer clinical trial
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback